Get Live Data

Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses
Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licensesView Video

Latest Share Chat

  2. Share Prices
  3. Angle Share Price
  4. Angle Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksAngle Share News (AGL)

Angle Information

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.50
Bid: 14.00
Ask: 15.00
Change: 0.50 (3.57%)
Spread: 1.00 (7.143%)
Open: 14.00
High: 15.00
Low: 14.00
Prev. Close: 14.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 22nd Apr 2021 16:10

Friday 23 April 
Record PLCTrading Statement
XPS Pensions Group PLCTrading Statement
Monday 26 April 
Draper Esprit PLCTrading Statement
International Biotechnology Trust PLCFull Year Results
Pearson PLCQ1 Results
United Oil & Gas PLCFull Year Results
Tuesday 27 April 
Anexo Group PLCFull Year Results
Aveva Group PLCTrading Statement
BP PLCQ1 Results
Egdon Resources PLCHalf Year Results
Focusrite PLCHalf Year Results
Gaming Realms PLCFull Year Results
HSBC Holdings PLCQ1 Results
Inspiration Healthcare Group PLCFull Year Results
IWG PLCQ1 Results
Nostrum Oil & Gas PLCFull Year Results
Property Franchise Group PLCFull Year Results
PZ Cussons PLCQ3 Results
Vivo Energy PLCQ1 Results
Whitbread PLCFull Year Results
Wednesday 28 April 
AB Dynamics PLCHalf Year Results
Brave Bison Group PLCFull Year Results
CRH PLCTrading Statement
French Connection Group PLCFull Year Results
Fresnillo PLCQ1 Production Results
GlaxoSmithKline PLCQ1 Results
HeiQ PLCFull Year Results
Home REIT PLCHalf Year Results
J Sainsbury PLCFull Year Results
Lloyds Banking Group PLCQ1 Results
London Stock Exchange Group PLCTrading Statement
LSL Property Services PLCFull Year Results
Nichols PLCTrading Statement
Pennant International Group PLCFull Year Results
Persimmon PLCTrading Statement
Reckitt Benckiser Group PLCQ1 Results
Renishaw PLCTrading Statement
RPS Group PLCTrading Statement
Tissue Regenix Group PLCFull Year Results
WPP PLCTrading Statement
Yamana Gold IncQ1 Results
Thursday 29 April 
Angle PLCFull Year Results
Appreciate Group PLCTrading Statement
C4X Discovery Holdings PLCHalf Year Results
ConvaTec Group PLCQ1 Results
Evraz PLCQ1 Results
Flutter Entertainment PLCQ1 Results
Glencore PLCQ1 Production Results
Howden Joinery Group PLCTrading Statement
Immotion Group PLCTrading Statement
Inchcape PLCQ1 Results
Indivior PLCQ1 Results
international Personal Finance PLCQ1 Results
Kerry Group PLCQ1 Results
Keystone Law Group PLCFull Year Results
Meggitt PLCQ1 Results
NatWest Group PLCQ1 Results
Proactis Holdings PLCHalf Year Results
Royal Dutch Shell PLCQ1 Results
RTW Venture Fund LtdFull Year Results
Schroders PLCQ1 Results
Shield Therapeutics PLCFull Year Results
Smith & Nephew PLCTrading Statement
St James's Place PLCQ1 Results
Standard Chartered PLCQ1 Results
Synthomer PLCQ1 Results
Unilever PLCQ1 Results
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
Xeros Technology Group PLCFull Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more
4 Jan 2024 16:54

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

Read more
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more
4 Jan 2024 12:09

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Read more
4 Jan 2024 10:43

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Jan 2024 08:58

LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs

(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest data from China.

Read more
4 Jan 2024 07:58

Angle receives 'breakthrough results' from DNA molecular analysis

(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.

Read more
2 Jan 2024 09:04

Angle locks in $250,000 contract with Eisai

(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

Read more
2 Jan 2024 08:51

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study worth USD250,000 to Angle. Angle will provide circulating-tumour-cells analysis using its Portrait HER2 assay to assess the response of breast cancer patients to Eisai's BB-1701 antibody-drug conjugate. BB-1701 targets HER2, a protein that speeds up the growth of breast cancer cells. Success in the phase two pilot study will offer the possibility for multiple follow-up studies.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.